A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 19 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Jun 2016 Planned End Date changed from 1 Nov 2016 to 1 Jul 2016.
- 13 Jun 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jul 2016.